IN2014DN07913A - - Google Patents
Info
- Publication number
- IN2014DN07913A IN2014DN07913A IN7913DEN2014A IN2014DN07913A IN 2014DN07913 A IN2014DN07913 A IN 2014DN07913A IN 7913DEN2014 A IN7913DEN2014 A IN 7913DEN2014A IN 2014DN07913 A IN2014DN07913 A IN 2014DN07913A
- Authority
- IN
- India
- Prior art keywords
- relates
- rosacea
- vesicular
- administering
- treatment
- Prior art date
Links
- 241001303601 Rosacea Species 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 201000004700 rosacea Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1205642.0A GB201205642D0 (en) | 2012-03-29 | 2012-03-29 | Vesicular formulations |
| PCT/EP2013/056694 WO2013144289A1 (fr) | 2012-03-29 | 2013-03-28 | Formulations vésiculaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07913A true IN2014DN07913A (fr) | 2015-04-24 |
Family
ID=46159988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7913DEN2014 IN2014DN07913A (fr) | 2012-03-29 | 2013-03-28 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9555051B2 (fr) |
| EP (1) | EP2830630A1 (fr) |
| JP (1) | JP2015511618A (fr) |
| KR (1) | KR20150004798A (fr) |
| CN (1) | CN104349782A (fr) |
| AU (1) | AU2013241701A1 (fr) |
| BR (1) | BR112014024033A8 (fr) |
| CA (1) | CA2867749A1 (fr) |
| CL (1) | CL2014002547A1 (fr) |
| CO (1) | CO7121334A2 (fr) |
| EA (1) | EA038899B1 (fr) |
| GB (2) | GB201205642D0 (fr) |
| IL (1) | IL234747A0 (fr) |
| IN (1) | IN2014DN07913A (fr) |
| MX (1) | MX2014011516A (fr) |
| NZ (1) | NZ700472A (fr) |
| PH (1) | PH12014502065A1 (fr) |
| SG (1) | SG11201406144TA (fr) |
| WO (1) | WO2013144289A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2486371A (en) | 2009-08-21 | 2012-06-13 | Targeted Delivery Technologies Ltd | Vesicular formulations |
| CN107257681A (zh) * | 2014-12-23 | 2017-10-17 | 卡姆拉斯公司 | 控释配制品 |
| ES2895910T3 (es) | 2015-06-30 | 2022-02-23 | Sequessome Tech Holdings Limited | Composiciones multifásicas |
| EP3681479B1 (fr) | 2017-09-15 | 2024-01-31 | Dyve Biosciences, Inc. | Bicarbonate de sodium pour utilisation dans le traitement de la goutte et de troubles associés |
| US20240299378A1 (en) * | 2021-02-25 | 2024-09-12 | Exinov | Emulsion for use in the treatment of rosacea |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60136511A (ja) | 1983-12-26 | 1985-07-20 | Eisai Co Ltd | 高尿酸血症治療剤 |
| JPS63501289A (ja) | 1985-09-27 | 1988-05-19 | ザ リ−ジエンツ オブ ザ ユニバ−シテイ オブ カリフオルニア | リポソ−ム経皮薬剤供給系 |
| JPS6295134A (ja) | 1985-10-21 | 1987-05-01 | Nippon Saafuakutanto Kogyo Kk | リポソ−ムの製造法 |
| US5015483A (en) | 1989-02-09 | 1991-05-14 | Nabisco Brands, Inc. | Liposome composition for the stabilization of oxidizable substances |
| US5498607A (en) | 1990-07-30 | 1996-03-12 | University Of Miami | Treatment for hypercholesterolemia |
| US6165500A (en) | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
| WO1992003122A1 (fr) | 1990-08-24 | 1992-03-05 | Gregor Cevc | Composition d'application de fines gouttelettes de substances actives |
| US5498420A (en) | 1991-04-12 | 1996-03-12 | Merz & Co. Gmbh & Co. | Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions |
| CA2139757C (fr) | 1992-07-08 | 2009-04-14 | Gunther Maierhofer | Liposomes, methode pour les preparer et leur utilisation pour la preparation de medicaments |
| FR2714382B1 (fr) | 1993-12-27 | 1996-02-02 | Roussel Uclaf | Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques. |
| DE4447287C1 (de) | 1994-12-30 | 1996-11-07 | Cevc Gregor | Präparat zum Wirkstofftransport durch Barrieren |
| US5902604A (en) | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
| FR2767691B1 (fr) | 1997-08-27 | 2000-02-18 | Oreal | Utilisation d'une dispersion a base de vehicules lipidiques comme composition anti-inflammatoire |
| US6534070B1 (en) * | 1997-11-19 | 2003-03-18 | Schering Aktiengesellschaft | Composition with azelaic acid |
| US6165997A (en) | 1997-11-20 | 2000-12-26 | Statens Serum Institut | Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
| BR9816014A (pt) | 1998-09-01 | 2001-05-08 | Idea Ag | Transporte eletricamente controlado de penetrantes carregados através de barreiras |
| DE69825495T2 (de) | 1998-12-23 | 2005-07-28 | Idea Ag | Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo |
| PT1031346E (pt) | 1999-01-27 | 2002-09-30 | Idea Ag | Vacinacao nao invasiva atraves da pele |
| US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| WO2001001962A1 (fr) | 1999-07-05 | 2001-01-11 | Idea Ag. | Procede d'amelioration du transport a travers des barrieres semi-permeables compatibles |
| US6248728B1 (en) | 2000-03-10 | 2001-06-19 | Kansas State University Research Foundation | Phosphatidylcholine compositions and methods for lowering intestinal absorption and plasma levels of cholesterol |
| US6191121B1 (en) * | 2000-04-06 | 2001-02-20 | Nicholas V. Perricone | Treatment of skin damage using polyenylphosphatidylcholine |
| DE60122304T2 (de) | 2000-04-12 | 2007-08-09 | Liplasome Pharma A/S | Auf lipiden basierendes system zur zielgerichteten verabreichung diagnostischer wirkstoffe |
| TWI281407B (en) | 2000-09-18 | 2007-05-21 | Vasogen Ireland Ltd | Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| US20030064948A1 (en) | 2001-02-08 | 2003-04-03 | Alfred Fahr | Invasomes for therapy of disorders, their preparation and use |
| PL367337A1 (pl) | 2001-05-31 | 2005-02-21 | Pharmacia Corporation | Przenikająca przez skórę kompozycja selektywnego inhibitora cyklooksygenazy-2 |
| US20050123593A1 (en) | 2001-06-25 | 2005-06-09 | Jonathan Thompson | Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| CA2368656A1 (fr) | 2002-01-21 | 2003-07-21 | Vasogen Ireland Limited | Appariement recepteur-ligand pour produire une reeaction anti-inflammatoire |
| AU2003233396B2 (en) | 2002-03-13 | 2007-05-24 | Thomas Skold | Water-based delivery systems |
| US20040009180A1 (en) | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
| JP2004131432A (ja) | 2002-10-11 | 2004-04-30 | Kumamoto Technology & Industry Foundation | 悪性腫瘍抑制剤 |
| US20040105881A1 (en) | 2002-10-11 | 2004-06-03 | Gregor Cevc | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| CN1703199B (zh) | 2002-10-11 | 2010-04-28 | 伊迪亚股份公司 | 具有增强的可变形性、包含至少三种两亲性物质的聚集物,其用于改善通过半透屏障的转运以及非侵入性药物在体内、具体是通过皮肤的应用 |
| JP2006525368A (ja) | 2003-05-02 | 2006-11-09 | アロネックス，ファーマシューティカルズ，インコーポレーテッド | 脂質白金錯体およびその使用方法 |
| EA200600297A1 (ru) | 2003-07-21 | 2006-08-25 | Васоджен Айеленд Лимитед | Лечение острого воспалительного состояния |
| JP2005179313A (ja) | 2003-12-24 | 2005-07-07 | Shu Uemura:Kk | 皮膚化粧料用基剤の製造方法および皮膚化粧料 |
| US7476432B2 (en) | 2004-05-28 | 2009-01-13 | Tecton Products | Phosphorescent pultrusion |
| CA2584475A1 (fr) | 2004-11-12 | 2006-05-18 | Idea Ag | Agregats a grande surface pour le traitement de troubles cutanes |
| WO2006086992A2 (fr) | 2005-02-18 | 2006-08-24 | Liplasome Pharma A/S | Systemes d'apport de medicament contenant des derives de promedicament lipidique degradant la phospholipase a2 et utilisations therapeutiques de ces derniers par exemple en tant qu'agents de guerison des blessures ou en tant que ligands de recepteurs actives par un proliferateur au peroxysome |
| US20070042008A1 (en) | 2005-08-18 | 2007-02-22 | Bodybio, Inc. | Compositions containing phosphatidylcholine and essential fatty acids |
| UA89545C2 (uk) | 2005-08-29 | 2010-02-10 | Сепсикюр Л.Л.К. | Спосіб лікування чи попередження станів, викликаних грампозитивними бактеріями |
| NZ569068A (en) | 2005-12-20 | 2011-11-25 | Cenestra Llc | Omega 3 fatty acid formulations of EPA and DHA |
| JP5009547B2 (ja) | 2006-03-31 | 2012-08-22 | 株式会社コーセー | 顔料とリポソームを含む化粧料 |
| US7544375B1 (en) | 2006-06-12 | 2009-06-09 | Swiss Skin Repair, Inc. | Composition |
| CA2664944C (fr) | 2006-09-28 | 2016-06-14 | Hadasit Medical Research Services & Development Limited | Utilisation de glycero-phospholipides pour une lubrication des articulations |
| JP4732307B2 (ja) * | 2006-11-20 | 2011-07-27 | 株式会社アンズコーポレーション | ナノエマルション及びそれを配合した化粧料 |
| US20100130611A1 (en) | 2006-12-20 | 2010-05-27 | Cenestra Llc | Omega 3 fatty acid formulations |
| EP1938801A1 (fr) | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoémulsion |
| US9511016B2 (en) | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
| ITVR20080006A1 (it) | 2008-01-23 | 2009-07-24 | David Ceretta | Apparato per la realizzazione di elementi d'impasto |
| ES2335636B1 (es) | 2008-02-29 | 2011-05-11 | Lipotec, S.A. | Composicion cosmetica o dermofarmaceutica de micelas mixtas. |
| JP2009256331A (ja) | 2008-03-25 | 2009-11-05 | Nagase Chemtex Corp | 高尿酸血症、又は痛風の予防、改善、又は治療剤 |
| US20100105139A1 (en) | 2008-10-27 | 2010-04-29 | Remco Alexander Spanjaard | Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents |
| KR20110128283A (ko) | 2009-02-05 | 2011-11-29 | 타겟티드 딜리버리 테크놀러지스 리미티드 | 미생물체의 증식 및 생존도를 감소시키는 방법 |
| CN105434353A (zh) | 2009-06-03 | 2016-03-30 | 斯昆申技术控股有限责任公司 | 用于治疗深部组织疼痛的制剂 |
| GB2486371A (en) | 2009-08-21 | 2012-06-13 | Targeted Delivery Technologies Ltd | Vesicular formulations |
| EP2382994A1 (fr) | 2010-04-26 | 2011-11-02 | Maurizio Victor Cattaneo | Nanocapsules ciblés à l'aide de ligands pour délivrer l'ARNi et d'autres agents |
| WO2011162802A1 (fr) | 2010-06-21 | 2011-12-29 | Virun, Inc. | Compositions contenant des composés non polaires |
| US20120045405A1 (en) | 2010-08-18 | 2012-02-23 | Gilman Miles E | Under eye cream |
| GB201206486D0 (en) | 2012-04-12 | 2012-05-30 | Sequessome Technology Holdings Ltd | Vesicular formulations and uses thereof |
| GB201208384D0 (en) | 2012-05-14 | 2012-06-27 | Sequessome Technology Holdings Ltd | Vesicular formulations, uses and methods |
| GB201208409D0 (en) | 2012-05-14 | 2012-06-27 | Sequessome Technology Holdings Ltd | Vesicular formulations, kits and uses |
| AU2014298426B2 (en) | 2013-07-31 | 2019-07-18 | Sequessome Technology Holdings Limited | Vesicles |
-
2012
- 2012-03-29 GB GBGB1205642.0A patent/GB201205642D0/en not_active Ceased
-
2013
- 2013-03-28 CA CA2867749A patent/CA2867749A1/fr not_active Abandoned
- 2013-03-28 WO PCT/EP2013/056694 patent/WO2013144289A1/fr not_active Ceased
- 2013-03-28 IN IN7913DEN2014 patent/IN2014DN07913A/en unknown
- 2013-03-28 NZ NZ700472A patent/NZ700472A/en not_active IP Right Cessation
- 2013-03-28 CN CN201380027033.9A patent/CN104349782A/zh active Pending
- 2013-03-28 MX MX2014011516A patent/MX2014011516A/es unknown
- 2013-03-28 AU AU2013241701A patent/AU2013241701A1/en not_active Abandoned
- 2013-03-28 EA EA201491581A patent/EA038899B1/ru unknown
- 2013-03-28 JP JP2015502351A patent/JP2015511618A/ja active Pending
- 2013-03-28 GB GB1419075.5A patent/GB2515440B/en not_active Expired - Fee Related
- 2013-03-28 KR KR1020147027498A patent/KR20150004798A/ko not_active Withdrawn
- 2013-03-28 EP EP13712801.3A patent/EP2830630A1/fr not_active Ceased
- 2013-03-28 US US14/388,469 patent/US9555051B2/en not_active Expired - Fee Related
- 2013-03-28 SG SG11201406144TA patent/SG11201406144TA/en unknown
- 2013-03-28 BR BR112014024033A patent/BR112014024033A8/pt not_active IP Right Cessation
-
2014
- 2014-09-17 PH PH12014502065A patent/PH12014502065A1/en unknown
- 2014-09-18 IL IL234747A patent/IL234747A0/en unknown
- 2014-09-25 CL CL2014002547A patent/CL2014002547A1/es unknown
- 2014-10-28 CO CO14238690A patent/CO7121334A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104349782A (zh) | 2015-02-11 |
| GB2515440B (en) | 2017-02-08 |
| BR112014024033A2 (fr) | 2017-06-20 |
| CO7121334A2 (es) | 2014-11-20 |
| JP2015511618A (ja) | 2015-04-20 |
| GB201205642D0 (en) | 2012-05-16 |
| SG11201406144TA (en) | 2014-10-30 |
| CA2867749A1 (fr) | 2013-10-03 |
| CL2014002547A1 (es) | 2015-03-27 |
| MX2014011516A (es) | 2015-04-08 |
| GB2515440A (en) | 2014-12-24 |
| BR112014024033A8 (pt) | 2017-07-25 |
| PH12014502065A1 (en) | 2014-12-10 |
| EP2830630A1 (fr) | 2015-02-04 |
| US20150057249A1 (en) | 2015-02-26 |
| EA038899B1 (ru) | 2021-11-03 |
| AU2013241701A1 (en) | 2014-10-16 |
| IL234747A0 (en) | 2014-11-30 |
| US9555051B2 (en) | 2017-01-31 |
| KR20150004798A (ko) | 2015-01-13 |
| NZ700472A (en) | 2016-02-26 |
| GB201419075D0 (en) | 2014-12-10 |
| WO2013144289A1 (fr) | 2013-10-03 |
| EA201491581A1 (ru) | 2015-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201103062D0 (en) | Method | |
| GB201118656D0 (en) | New compounds | |
| EA033374B9 (ru) | Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения | |
| PH12015502075A1 (en) | Treatment of cataplexy | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| MX349004B (es) | Nuevos compuestos. | |
| MX366899B (es) | Nuevos compuestos. | |
| MY183534A (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| PH12014502757B1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| UA118610C2 (uk) | Спіроциклічні інгібітори катепсину c | |
| PH12014502032A1 (en) | Treatment of brain cancer | |
| PH12014502558B1 (en) | Drug for preventing and/or treating polycystic kidney disease | |
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| PH12014502065A1 (en) | Vesicular formulations | |
| MX343968B (es) | Inhibidor de proteasoma delanzomib para uso en el tratamiento de lupus. | |
| MX356317B (es) | Tratamiento de síntomas asociados a gastroparesia femenina. | |
| IN2014DN03010A (fr) | ||
| IN2013MU03118A (fr) | ||
| EA201590615A1 (ru) | Стимулирующие лактацию композиции на основе фосфатидилсерина | |
| NZ728612A (en) | Treatment of androgen deprivation therapy associated symptoms | |
| GEP201706614B (en) | Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process | |
| HK1202249A1 (en) | Vesicular formulations | |
| NZ750581A (en) | Compositions and methods for treating neurodegenerative diseases and cardiomyopathy |